2Raffa RB. A novel approach to the pharmacology of analgesics. Am J Med, 1996,101 (1A) :40s.
3Markenson JA. Mechanisms of chronic pain. Am J Med, 1996,101 (1A) :6s.
4J. S. HAN. The role of central catecholamine in acupuncture analgesic. Chinese medical journal. 1979 -92 ( 11 ) :793.
5Walker JM, Bowen WD, Walker FO, et al. Sigma receptors : biology and function. Pharmacol Rev, 1990,42(4) :355-402.
6Bowen WD, Moses EL, Tolentino PJ, et al. Metabolites of halo- peridol display preferential activity at - receptors compared to do- pamine D-2 receptors. Eur J Pharmacol, 1990,177(3) :111-118.
7Jaen JC, Caprathe BW, Pugsley TA, et al. Evaluation of the effects of the enantiomers of reduced haloperidol, azapeml, and re- lated 4-amino-l-arylbutanols on dopamine and σ receptors. J Med Chem,1993, 36(24) :3929-3936.
8Matsumoto RR, Pouw B. Correlation between neuroleptic binding to σ1 and σ2 receptors and acute dystonic reactions. Eur J Pharmacol,2000, 401 (2) :155-160.
9Cendan CM, Pujahe JM, Portillo-Salido E, et al. Formalin-in- duced pain is reduced in σ1 receptor knockout mice. Eur J Pharmacol,2005, 511 (1) :73-74.
10Chien CC, Pastemak GW. Selective antagonism of opioid analgesi- a by a sigma system. J Pharmacol Exp Ther, 1994, 271 (3) :1583- 1590.
